Palbace 125 Mg
$2,000 – $5,700
|Manufacturer||Pfizer India Ltd|
|Pack Size||Price||Price Per Unit||Qty||Add To Cart|
|21 Capsule S||$2000||$95.23|
|42 Capsule S||$3900||$92.85|
|63 Capsule S||$5700||$90.47|
Palbace 125 Mg
Palbace 125 Mg palbociclib by Pfizer is a cancer drug that interferes with the growth and spread of cancer cells in the body.
Palbace 125 Mg is generally used in combination with letrozole or fulvestrant for treating certain types of advanced breast cancer in postmenopausal women. It is also given in combination with another cancer medicine, either letrozole or fulvestrant.
Palbace 125 Mg is a renamed version of the drug Ibrance for the Indian market. It is approved by the US Food and Drug Administration (FDA). In clinical studies, palbociclib appeared to improve the survival time of patients.
Drug = Palbociclib
Strength = 125 Mg
Manufacturer = Pfizer Ltd
How To Take
Take Palbace 125 Mg in the dose and duration as advised by your doctor. Swallow it as a whole. Do not chew, crush or break it. Palbace 125 Mg is to be taken with food.
Palbace 125 Mg
Nausea and Vomiting
Hair loss or thinning of the hair
Lack or loss of strength
Decrease in white blood cells and platelets
Chills and fever
Pregnancy – Palbace 125 Mg is not recommended for use in pregnant women unless absolutely necessary. Discuss all the risks and benefits with your doctor before taking this medicine.
Breast-feeding – Palbace 125 Mg is not recommended for use in breastfeeding women unless absolutely necessary. Discuss all the risks and benefits with your doctor before taking this medicine. Your doctor may advise you to discontinue breastfeeding or to discontinue the medicine based on your clinical condition.
Neutropenia – Palbace 125 Mg may cause neutropenia (decrease in white blood cells) in some patients. A decrease in white blood cell count may render the patient prone to serious and opportunistic infections. Report any unusual symptoms such as a fever, chills, sore throat, etc. to the doctor immediately. Close monitoring of blood cell counts is recommended during treatment with this medicine. Appropriate dose adjustments or replacement with a suitable alternative may be required based on the clinical condition.
Infections – Since Palbace 125 Mg can cause bone marrow suppression, the patients are susceptible to serious and opportunistic infections. Report any symptoms such as a fever, chills, shortness of breath, sore throat, etc. to the doctor immediately. Appropriate corrective measures, dose adjustments, or replacement with a suitable alternative may be required based on the clinical condition.
Use in children – Palbace 125 Mg is not recommended for use in patients below 18 years of age since the safety and efficacy of use are not clinically established.
Palbace 125 Mg is used to treat a certain type of breast cancer. It is a chemotherapy drug that works by slowing or stopping the growth of cancer cells.